Share Price of Aurobindo Pharma Limited edged decrease by greater than two per cent on Tuesday, June 1, a day after the pharmaceutical firm introduced its January-March quarter outcomes for the monetary yr 2020-21. On Tuesday, Aurobindo Pharma opened on the BSE at Rs 1,000, inching to an intra day excessive of Rs 1,007.95, and an intra day low of Rs 959.90, by means of the buying and selling session to this point. According to a regulatory submitting by the agency to the inventory exchanges, Aurobindo Pharma reported a web revenue of Rs 801.18 crore consolidated foundation within the fourth quarter of fiscal 2020-21.
According to the assertion, Aurobindo Pharma reported a consolidated web revenue of Rs 863.16 crore for the corresponding quarter of the earlier fiscal. The firm’s income from operations for the March quarter stood at Rs 6,0001.50 crore. In the identical quarter of the earlier fiscal, its income from operations stood at Rs 6,158.43 crore.
The pharma firm acknowledged that the online revenue after the JV share, minority curiosity just isn’t comparable attributable to Natrol divestment. For the complete monetary yr 2020-21, Aurobindo Pharma posted a web revenue of Rs 5,333.83 crore, in comparison with a revenue of Rs 2,843.67 crore within the year-ago interval.
On the NSE, Aurobindo Pharma opened at Rs 1,003.01, swinging to an intra day excessive of Rs 1,008.60, and an intra day low of Rs 959.25, within the session to this point. It was final buying and selling 2.40 per cent at Rs 974 on the NSE.
Shares of Aurobindo Pharma had been final buying and selling 2.27 per cent decrease at Rs 975.10 on the BSE.